Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase
- PMID: 3015002
- PMCID: PMC180389
- DOI: 10.1128/AAC.29.1.171
Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase
Abstract
This study was performed to obtain information on the enzymatic background to the antiviral activity of acyclic guanosine analogs. Five acyclic guanosine analogs, the (R)- and (S)-enantiomers of 9-(3,4-dihydroxybutyl)guanine, 9-(4-hydroxybutyl)guanine, 9-[(2-hydroxyethoxy)methyl]guanine, and 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine, were compared in enzyme kinetic experiments using purified varicella-zoster virus and human placenta mitochondrial thymidine kinase (TK). All analogs showed competitive patterns of inhibition in the phosphorylation of thymidine by varicella-zoster virus TK, but only low affinities and phosphorylation rates were observed. No affinity for the mitochondrial TK was observed for any of the analogs.
Similar articles
-
Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.Antimicrob Agents Chemother. 1987 Jan;31(1):76-80. doi: 10.1128/AAC.31.1.76. Antimicrob Agents Chemother. 1987. PMID: 3032092 Free PMC article.
-
Phosphorylation of four acyclic guanosine analogs by herpes simplex virus type 2 thymidine kinase.Antimicrob Agents Chemother. 1984 Apr;25(4):524-6. doi: 10.1128/AAC.25.4.524. Antimicrob Agents Chemother. 1984. PMID: 6329085 Free PMC article.
-
Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.J Virol. 1979 Jul;31(1):172-7. doi: 10.1128/JVI.31.1.172-177.1979. J Virol. 1979. PMID: 228052 Free PMC article.
-
[Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].Rinsho Byori. 1985 Feb;33(2):148-57. Rinsho Byori. 1985. PMID: 2987573 Review. Japanese. No abstract available.
-
Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):287-95. doi: 10.1016/s0925-4439(02)00091-1. Biochim Biophys Acta. 2002. PMID: 12084470 Review.
Cited by
-
Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.J Mol Model. 2014 Jul;20(7):2321. doi: 10.1007/s00894-014-2321-6. Epub 2014 Jun 25. J Mol Model. 2014. PMID: 24961898
-
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.Antiviral Res. 2014 Oct;110:10-9. doi: 10.1016/j.antiviral.2014.07.007. Epub 2014 Jul 19. Antiviral Res. 2014. PMID: 25051026 Free PMC article.
-
Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.Mol Cell Biochem. 1990 Jan 18;92(1):23-35. doi: 10.1007/BF00220716. Mol Cell Biochem. 1990. PMID: 2155379
-
Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.Antimicrob Agents Chemother. 1988 Aug;32(8):1137-42. doi: 10.1128/AAC.32.8.1137. Antimicrob Agents Chemother. 1988. PMID: 2847643 Free PMC article.
-
Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.Antimicrob Agents Chemother. 1987 Jan;31(1):76-80. doi: 10.1128/AAC.31.1.76. Antimicrob Agents Chemother. 1987. PMID: 3032092 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources